Notification of a Public Teleconference of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission), 29584-29585 [2017-13650]

Download as PDF sradovich on DSK3GMQ082PROD with NOTICES 29584 Federal Register / Vol. 82, No. 124 / Thursday, June 29, 2017 / Notices security and associated records. Proposed for permanent retention are records relating to significant case files and site histories. 2. Department of Health and Human Services, National Institutes of Health (DAA–0443–2017–0002, 1 item, 1 temporary item). Agency-wide research records that support intellectual property rights consisting of project documentation that supports patents or invention rights. 3. Department of Homeland Security, United States Citizenship and Immigration Services (DAA–0566– 2017–0025, 1 item, 1 temporary item). Master files of an electronic information system used to create duty schedules for asylum officers to conduct interviews. 4. Department of Justice, Criminal Division (DAA–0060–2017–0024, 3 items, 3 temporary items). Case files, transfer applications, and working files related to international prisoner transfers which allow prisoners to serve sentences in their home countries under treaty agreements. 5. Department of the Navy, Agencywide (DAA–NU–2015–0004, 47 items, 39 temporary items). Records relating to logistics including routine correspondence, maintenance records, training papers, daily operations, exchange operations, inventory, and related matters. Proposed for permanent retention are records relating to policy, security assistance, ship inspection, command strategy, publications, loans and gifts, and equipment and allowance tables. 6. Administrative Office of the United States Courts, United States District Courts (DAA–0021–2017–0001, 2 items, 1 temporary item). Records of seven new Civil Nature of Suit Codes to include cases that do not reach trial for False Claims, Family and Medical Leave, Arbitration, and Administrative Procedures. Proposed for permanent retention are cases that reach ‘‘issue joined’’ for Personal InjuryPharmaceutical, Civil Rights-Education, and Civil Detainee-Conditions of Confinement. 7. Central Intelligence Agency, Directorate of Digital Innovation (DAA– 0263–2016–0001, 2 items, 2 temporary items). Obsolete card indexing and retrieval system for records now maintained by the Office of Information Management Services. 8. General Services Administration, Agency-wide (DAA–0269–2016–0007, 4 items, 3 temporary items). Communication program records to include speeches and official communication, records related to special events, ceremonies, and dedications, and program management VerDate Sep<11>2014 18:29 Jun 28, 2017 Jkt 241001 records. Proposed for permanent retentions are speeches and official communication of administrators, commissioners, and heads of staff and service offices. 9. General Services Administration, Agency-wide (DAA–0269–2016–0008, 4 items, 2 temporary items). Records relating to legislative and Congressional affairs including legislative program records and Congressional property records. Proposed for permanent retention are legislation case files and legislative program reports. 10. General Services Administration, Agency-wide (DAA–0269–2016–0009, 2 items, 2 temporary items). Records relating to special employment categories such as detailees, interns and executive service, and human resources program management. 11. Securities and Exchange Commission, Division of Enforcement (DAA–0266–2017–0009, 1 item, 1 temporary item). Records of financial obligations related to disgorgement, penalties, fees, and interest. Laurence Brewer, Chief Records Officer for the U.S. Government. [FR Doc. 2017–13604 Filed 6–28–17; 8:45 am] BILLING CODE 7515–01–P EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy Notification of a Public Teleconference of the President’s Commission on Combating Drug Addiction and the Opioid Crisis (Commission) Office of National Drug Control Policy (ONDCP) ACTION: Notice of teleconference. AGENCY: ONDCP announces a meeting by teleconference of the President’s Commission on Combating Drug Addiction and the Opioid Crisis. The purpose of the meeting is to review a draft interim report that will be posted on ONDCP’s Commission Web site listed below before the teleconference. DATES: The teleconference will be held on Monday July 17, 2017 at 4:00 p.m. (Eastern time). ADDRESSES: There will be no physical address. The public may call (800) 260– 0718 (Access Code 426289) to listen. Please call five minutes before the start time. If you are part of an organization, please try to consolidate use to as few lines as possible. FOR FURTHER INFORMATION CONTACT: General information concerning the SUMMARY: PO 00000 Frm 00111 Fmt 4703 Sfmt 4703 Commission and its meetings can be found on ONDCP’s Web site at https:// www.whitehouse.gov/ondcp/presidentscommission. Any member of the public wishing to obtain information about the Commission or its meetings that is not already on ONDCP’s Web site or who wishes to submit written comments for the Commission’s consideration may contact Michael Passante, Designated Federal Officer (DFO) via email at commission@ondcp.eop.gov or telephone at (202) 395–6709. Please note that ONDCP may post such written comments publicly on our Web site, including names and contact information that are submitted. There will not be oral comments from the public on the teleconference. Requests to accommodate disabilities should also be sent to that email address, preferably at least 10 days prior to the meeting to allow time for processing. SUPPLEMENTARY INFORMATION: The Commission was established in accordance with E.O. 13784 of March 29, 2017, the Commission’s charter, and the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App. 2, to obtain advice and recommendations for the President regarding drug issues. The Executive Order, charter, and information on the Members of the Commission are available on ONDCP’s Web site. The Commission will function solely as an advisory body and will make recommendations regarding policies and practices for combating drug addiction with particular focus on the current opioid crisis in the United States. The Commission’s final report is due October 1, 2017 unless there is an extension. Per E.O. 13784, the Commission shall: a. Identify and describe the existing Federal funding used to combat drug addiction and the opioid crisis; b. Assess the availability and accessibility of drug addiction treatment services and overdose reversal throughout the country and identify areas that are underserved; c. Identify and report on best practices for addiction prevention, including healthcare provider education and evaluation of prescription practices, collaboration between State and Federal officials, and the use and effectiveness of State prescription drug monitoring programs; d. Review the literature evaluating the effectiveness of educational messages for youth and adults with respect to prescription and illicit opioids; e. Identify and evaluate existing Federal programs to prevent and treat drug addiction for their scope and E:\FR\FM\29JNN1.SGM 29JNN1 Federal Register / Vol. 82, No. 124 / Thursday, June 29, 2017 / Notices effectiveness, and make recommendations for improving these programs; and; f. Make recommendations to the President for improving the Federal response to drug addiction and the opioid crisis. Dated: June 26, 2017. Michael Passante, Acting General Counsel, Designated Federal Officer. [FR Doc. 2017–13650 Filed 6–28–17; 8:45 am] BILLING CODE 3280–F5–P NUCLEAR REGULATORY COMMISSION [NRC–2016–0183] Information Collection: NRC Form 749, ‘‘Manual License Verification Report’’ Nuclear Regulatory Commission. ACTION: Notice of submission to the Office of Management and Budget; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) invites public comment on the renewal of Office of Management and Budget (OMB) approval for an existing collection of information. The information collection is titled NRC Form 749, ‘‘Manual License Verification Report.’’ DATES: Submit comments by July 31, 2017. ADDRESSES: Submit comments directly to the OMB reviewer at: Aaron Szabo, Desk Officer, Office of Information and Regulatory Affairs (3150–0223), NEOB– 10202, Office of Management and Budget, Washington, DC 20503; telephone: 202–395–3621, email: oira_ submission@omb.eop.gov. FOR FURTHER INFORMATION CONTACT: David Cullison, NRC Clearance Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: Infocollects.Resource@nrc.gov. SUPPLEMENTARY INFORMATION: SUMMARY: sradovich on DSK3GMQ082PROD with NOTICES I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2016– 0183 when contacting the NRC about the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2016–0183. A copy of the collection of information and VerDate Sep<11>2014 18:29 Jun 28, 2017 Jkt 241001 related instructions may be obtained without charge by accessing Docket ID NRC–2016–0183 on this Web site. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The Supporting Statement and NRC Form 749 ‘‘Manual License Verification Report’’ are available in ADAMS under Accession Nos. ML177173A878 and ML16335A194. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting the NRC’s Clearance Officer, David Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: Infocollects.Resource@nrc.gov. B. Submitting Comments The NRC cautions you not to include identifying or contact information in comment submissions that you do not want to be publicly disclosed in your comment submission. All comment submissions are posted at https:// www.regulations.gov and entered into ADAMS. Comment submissions are not routinely edited to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the OMB, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that comment submissions are not routinely edited to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Background Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the NRC recently submitted a request for renewal of an existing collection of information to PO 00000 Frm 00112 Fmt 4703 Sfmt 9990 29585 OMB for review titled, NRC Form 749, ‘‘Manual License Verification Report.’’ The NRC hereby informs potential respondents that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The NRC published a Federal Register notice with a 60-day comment period on this information collection on March 23, 2017 (82 FR 14919). 1. The title of the information collection: NRC Form 749, ‘‘Manual License Verification Report.’’ 2. OMB approval number: 3150–0223. 3. Type of submission: Extension. 4. The form number if applicable: NRC Form 749. 5. How often the collection is required or requested: On occasion. Licensees subject to 10 CFR part 37, ‘‘Physical Protection of Byproduct Material’’ license verification requirements must verify the legitimacy of the license with the issuing agency prior to transferring radioactive materials in quantities of concern. 6. Who will be required or asked to respond: Licensees are required to complete a license verification under the circumstances noted in 4 above. A License Verification System (LVS) is available to provide an electronic method for fulfilling this requirement. In cases where a licensee is unable to use the LVS to perform a verification, they will provide NRC Form 749 for manual license verification. 7. The estimated number of annual responses: 456. 8. The estimated number of annual respondents: 456. 9. An estimate of the total number of hours needed annually to comply with the information collection requirement or request: 46 hours. 10. Abstract: When a licensee is unable to use the License Verification System to perform their license verification prior to transferring radioactive materials in quantities of concern, a manual process is available, in which licensees submit the NRC Form 749, ‘‘Manual License Verification Report.’’ The form provides the information necessary for the license issuing agencies to perform the verification on behalf of the licensee transferring the radioactive materials. For the Nuclear Regulatory Commission. David Cullison, NRC Clearance Officer, Office of the Chief Information Officer. [FR Doc. 2017–13614 Filed 6–28–17; 8:45 am] BILLING CODE 7590–01–P E:\FR\FM\29JNN1.SGM 29JNN1

Agencies

[Federal Register Volume 82, Number 124 (Thursday, June 29, 2017)]
[Notices]
[Pages 29584-29585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13650]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Notification of a Public Teleconference of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis 
(Commission)

AGENCY: Office of National Drug Control Policy (ONDCP)

ACTION: Notice of teleconference.

-----------------------------------------------------------------------

SUMMARY: ONDCP announces a meeting by teleconference of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis. The 
purpose of the meeting is to review a draft interim report that will be 
posted on ONDCP's Commission Web site listed below before the 
teleconference.

DATES: The teleconference will be held on Monday July 17, 2017 at 4:00 
p.m. (Eastern time).

ADDRESSES: There will be no physical address. The public may call (800) 
260-0718 (Access Code 426289) to listen. Please call five minutes 
before the start time. If you are part of an organization, please try 
to consolidate use to as few lines as possible.

FOR FURTHER INFORMATION CONTACT: General information concerning the 
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the 
public wishing to obtain information about the Commission or its 
meetings that is not already on ONDCP's Web site or who wishes to 
submit written comments for the Commission's consideration may contact 
Michael Passante, Designated Federal Officer (DFO) via email at 
commission@ondcp.eop.gov or telephone at (202) 395-6709. Please note 
that ONDCP may post such written comments publicly on our Web site, 
including names and contact information that are submitted. There will 
not be oral comments from the public on the teleconference. Requests to 
accommodate disabilities should also be sent to that email address, 
preferably at least 10 days prior to the meeting to allow time for 
processing.

SUPPLEMENTARY INFORMATION: The Commission was established in accordance 
with E.O. 13784 of March 29, 2017, the Commission's charter, and the 
provisions of the Federal Advisory Committee Act (FACA), as amended, 5 
U.S.C. App. 2, to obtain advice and recommendations for the President 
regarding drug issues. The Executive Order, charter, and information on 
the Members of the Commission are available on ONDCP's Web site. The 
Commission will function solely as an advisory body and will make 
recommendations regarding policies and practices for combating drug 
addiction with particular focus on the current opioid crisis in the 
United States. The Commission's final report is due October 1, 2017 
unless there is an extension. Per E.O. 13784, the Commission shall:
    a. Identify and describe the existing Federal funding used to 
combat drug addiction and the opioid crisis;
    b. Assess the availability and accessibility of drug addiction 
treatment services and overdose reversal throughout the country and 
identify areas that are underserved;
    c. Identify and report on best practices for addiction prevention, 
including healthcare provider education and evaluation of prescription 
practices, collaboration between State and Federal officials, and the 
use and effectiveness of State prescription drug monitoring programs;
    d. Review the literature evaluating the effectiveness of 
educational messages for youth and adults with respect to prescription 
and illicit opioids;
    e. Identify and evaluate existing Federal programs to prevent and 
treat drug addiction for their scope and

[[Page 29585]]

effectiveness, and make recommendations for improving these programs; 
and;
    f. Make recommendations to the President for improving the Federal 
response to drug addiction and the opioid crisis.

    Dated: June 26, 2017.
Michael Passante,
Acting General Counsel, Designated Federal Officer.
[FR Doc. 2017-13650 Filed 6-28-17; 8:45 am]
 BILLING CODE 3280-F5-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.